Is using a single very long drug‑eluting stent (e.g., 44 mm or 52 mm) to cover a diffusely diseased coronary segment an acceptable strategy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 19, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the preoperative cardiac evaluation considerations for an adult patient with a history of coronary artery disease, recent drug-eluting stent placement 50 days ago, and an enterocutaneous fistula, who is being considered for an exploratory laparotomy?

Is a stent (small, mesh tube) always placed when clearing a coronary artery?

What is the recommended duration of ticagrelor therapy for a patient with a drug-eluting stent after angioplasty?

What is the recommended time frame for administering erythropoietin (EPO) after vascular stent placement?

What are the properties of each generation of cardiac stent?

What antipsychotic options are appropriate for an adult with bipolar I disorder who developed akathisia on aripiprazole (Abilify) and cariprazine?

What alternatives exist to blenderized (homemade) enteral tube feeding?

What does a blood urea nitrogen of 4 mg/dL and a BUN‑to‑creatinine ratio of 6 indicate in a patient with an estimated glomerular filtration rate of 119 mL/min/1.73 m²?

What is the normal serum potassium range in children?

Can duloxetine (Cymbalta) be combined with bupropion (Wellbutrin) for depression/anxiety or chronic pain, and what are the recommended dosing limits and precautions regarding seizure risk and blood pressure monitoring?

Can sacubitril/valsartan be started in a patient with end‑stage renal disease (eGFR 8 mL/min/1.73 m²), markedly elevated alanine aminotransferase (ALT 582 U/L) from hepatic congestion, and NT‑proBNP >35 000 pg/mL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.